Points to consider in the evaluation of biopharmaceuticals

I Kramer, R Tredree, Arnold Vulto

Research output: Contribution to journalArticleAcademic

Abstract

The pharmacist, as the medicines expert, should be able to assess the quality and safety of a biopharmaceutical and needs to know which criteria to use for the evaluation. A checklist incorporates the regulatory requirements and gives guidance when choosing biopharmaceuticals and biosimilars.
Original languageUndefined/Unknown
Pages (from-to)73-76
Number of pages4
JournalEJHP Practice
Volume14
Issue number1
Publication statusPublished - 2008

Cite this